Berkeley Lovelace Jr.
CNBC
New York, NY, United States
Contact Berkeley
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Berkeley:
Experimental vaccine shows promise in delaying the return of aggressive brain tumor
The vaccine was shown to nearly double the survival time in a trial of 63 patients. Researchers now hope to confirm the findings in a larger trial. → Read More
More gay and bisexual men can donate blood under new FDA rules
Most gay and bisexual men who are in a monogamous relationship with another man will no longer need to abstain from sex to donate blood. → Read More
CDC signs off on 2nd dose of omicron Covid booster for older adults
People 65 and up can get another dose of the updated Covid vaccine at least four months after their first updated booster. → Read More
Cancer drug shortages are creating dire circumstances for some patients
In some cases, other drugs are available, but they may not work as well. In other cases, patients may die waiting for the medications they need. → Read More
FDA to require mammogram providers to notify women about breast density to help detect breast cancer sooner
New FDA guidelines require women with dense breasts to be notified after getting a mammogram. The new rules may help more women detect breast cancer earlier. → Read More
Eli Lilly caps the cost of insulin at $35 a month
The move puts the drugmaker in line with a popular provision in the Inflation Reduction Act that capped the medication’s cost for seniors on Medicare. → Read More
A calorie-restricted diet may slow aging in healthy adults, science shows
Eating fewer calories appears to slow the pace of aging and increase longevity in healthy adults, according to a study published Thursday in the journal Nature Aging. → Read More
Updated Covid boosters cut the infection risk from XBB.1.5 subvariant by nearly half, CDC finds
The report provides the first data on how the updated shots fare against the predominant strain in the U.S. → Read More
People with diabetes struggle to find Ozempic as it soars in popularity as a weight loss aid
Ozempic is the same medication as the popular weight loss drug Wegovy, just at a lower dose. → Read More
A new Alzheimer’s drug will cost $26,500 a year. Who will be able to get it?
A newly approved drug intended to slow the progression of Alzheimer’s disease offers patients hope, but it will come with a steep price tag: $26,500 a year. → Read More
Reports of young children accidentally eating marijuana edibles soar
Edibles are often packaged to look like candy, and children, unaware of the risk, may find them appealing. → Read More
Mark Cuban’s next act on drug costs: Tackling insulin
The billionaire's online drug business is able to offer lower prices by buying medications directly from manufacturers. → Read More
FDA approves 1st drug to delay the onset of Type 1 diabetes
The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up. → Read More
FDA opens door to make opioid overdose antidote available over the counter
Over-the-counter versions of naloxone, a lifesaving drug that can reverse opioid overdoses, could begin appearing on pharmacy shelves as early as next year. → Read More
These are the signs and symptoms of flu, RSV and Covid in kids
RSV and other respiratory viruses are spreading in children. RSV symptoms include cough and it can be severe in babies and toddlers. There is no vaccine or treatment. → Read More
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth
Makena, the only drug approved to prevent premature births, has not shown to be effective and exposes women to “serious risk," the agency's scientists said. → Read More
As Covid cases rise slightly in children, FDA clears omicron booster for kids as young as 5
Children's Covid vaccine targeted to omicron was authorized by the FDA Wednesday. The move comes as cases of omicron in children are increasing slightly. → Read More
FDA approves controversial new drug designed to slow the progress of ALS
The Food and Drug Administration on Thursday approved a new drug to slow the progression of ALS, a fatal neurodegenerative disease for which there is no cure. → Read More
The Inflation Reduction Act aims to lower drug costs — but here’s how Big Pharma could get around it
The Inflation Reduction Act has provisions to lower drug costs, but it's possible that pharma companies could get around them, and keep drug prices high. → Read More
New Covid boosters look a lot like the old ones. Doctors worry that could lead to errors.
Experts are concerned that the updated Covid boosters look too similar to previous versions of the vaccine, and people could receive the wrong dose in error. → Read More